Antibodies to TRIM46 are associated with paraneoplastic neurological syndromes.
van Coevorden-Hameete M.H., van Beuningen SFB, Perrenoud M., Will L.M., Hulsenboom E., Demonet J.F., Sabater L., Kros J.M., Verschuuren JJGM, Titulaer M.J. et al., 2017/09. Annals of clinical and translational neurology, 4 (9) pp. 680-686. Peer-reviewed.
ici le détail